FARMACO SA
Company details
- Defunct NIF/CIF: A27024132
-
Telephone: Not available
-
Date of last BORME entry: 17/03/2009
-
Sector: Manufacturing
-
Address: Not available
-
Website: Not available
-
Featured products:
More information on FARMACO SA
-
17/03/2009 | BORME act no.: 133448 | Register: LUGOFe de erratas -
21/12/2000 | BORME act no.: 443897 | Register: LUGOCeses/Dimisiones
-
21/12/2000 | BORME act no.: 443897 | Register: LUGONombramientos
-
21/12/2000 | BORME act no.: 443897 | Register: LUGODisolución
-
23/10/2000 | BORME act no.: 366317 | Register: LUGOReapertura hoja registral
-
08/05/2000 | BORME act no.: 174440 | Register: LUGOCierre provisional hoja registral art 276, 277 Rglto del Impuesto de Sociedades
-
16/09/1999 | BORME act no.: 335384 | Register: LUGODepósito de cuentas anuales (julio de 1999)
Other information
The CIF assigned to FARMACO SA is A27024132, and its commercial status is defunct. The company is engaged in economic activities classified under the CNAE 1013 - Elaboración de productos cárnicos y de volatería. Additionally, it is categorized with the SIC code -.
FARMACO SA employs approximately Between 10 and 49 employees and records an annual turnover of less than 2 million euros. The company is registered in the Commercial Registry of Lugo, and has 1 registration charges. The most recent announcement in Borme was published on 17/03/2009, while the last deposit of ordinary annual accounts corresponds to the year -.
To find out the contact information of FARMACO SA, such as the telephone number, postal address, or website, you can access the Company Data module.
If you wish to obtain additional information about FARMACO SA, we invite you to consult any of the available financial reports, the Annual Accounts of the company, or review the incidents of defaults registered in the RAI delinquency file.
The financial, commercial, and legal information about FARMACO SA comes from official data sources and is automatically updated every day.
Do you want to know more about FARMACO SA??
Find out more about this company by consulting these reports:
